GLP‑1 drugs like Ozempic, Wegovy, and Mounjaro are dominating headlines in the U.S. for their powerful effects on weight loss and metabolic health. Some call it a revolution in chronic disease treatment, while others worry about cost, access, and long-term safety.
We want to hear your thoughts:
Are GLP‑1 medications truly reshaping the future of health - or is the hype outpacing the science?